Close Menu

NEW YORK – OraSure Technologies reported after the close of the market on Wednesday that its second quarter revenues fell 25 percent year over year, with a decline in revenues for genomics and infectious disease testing products offsetting increased revenues in specimen collection devices.

For the three months ended June 30, the Bethlehem, Pennsylvania-based company reported revenues of $29.3 million, down from $38.8 million a year earlier and missing the analysts' average estimate of $32.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.